1. Home
  2. /
  3. Featured


August 2017

COAnalyzer Benchmarking Software for Practices

The Community Oncology Alliance (COA) and COA Pharmacy Association (COPA) has launched COAnalyzer.Net a new, completely free benchmarking tool for managing your oncology practices. It allows practices to maximize operations with real-time data.

Read Full
December 2018

COA Comments on IPI for Medicare Part B Drugs

The Honorable Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-5528-ANPRM P.O. Box 8016 Baltimore, MD 21244-8013 Re: Medicare Program; International Pricing Index Model for Medicare Part B Drugs; CMS-5528- ANPRM Dear Administrator Verma: On behalf of the Board of Directors of the Community Oncology Alliance (COA),

Download (PDF) Read Full
April 2019

COA Biosimilars Position Statement

Summary: The Community Oncology Alliance (COA) is committed to advancing knowledge and acceptance of biosimilars as an important, promising element in reducing drug costs and overall health care spending, and the financial toxicity of cancer care for patients. COA will work to support biosimilars and innovative biosimilar (biologic) development with all stakeholders, including policymakers,

Download (PDF) Read Full